A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with placebo, in the acute treatment of migraine.
A minimum of 12 months of spontaneous amenorrhea or [+11]
Is a female who is pregnant, breast-feeding, or intends to become pregnant durin... [+35]